My mentioning and citing material to do with recreational or medical use of controlled substances should obviously not be taken as an endorsement of recreational use of controlled substances. I am not qualified to make such endorsements, even if I were inclined to. Indeed, if you are turning to a mathematician for intelligence on on legal of pharmacological questions, you should probably inspect your life decisions to see if any other ones you have made recently are as terrible.
Eventually I’d like to talk about medicalisation, and how drugs for diseases are socially accepted, drugs for things that aren’t diseases are denounced, and what a disease is, is negotiated based on… what? These all interact with the patent system in amusing ways.
Recreational drug usage and legality
Dr Karen Hitchcock had a nice turn of phrase, which I would like to transcribe from the podcast when I have time.
There are two key problems with books that attempt to be objective about illegal drugs. The first is that for the most part their authors won’t admit to having used such substances for fear their own objectivity may be compromised. The second follows fairly logically from the first: who, precisely, are such books aimed at? If they are targeted at readers who already have a consuming interest in drugs (pun intended), then they are very likely – by definition – to know rather more about the subject than the author; and if they are for people who only have a tangential interest in the subject, why should they want to read about it at all?
Psychedelics to treat mental illness
Psychedelics and political orientation
Becker, Gary S., and Kevin M. Murphy. 1988. “A Theory of Rational Addiction.” The Journal of Political Economy, 675–700.
Bressloff, Paul C., Jack D. Cowan, Martin Golubitsky, Peter J. Thomas, and Matthew C. Wiener. 2001. “Geometric Visual Hallucinations, Euclidean Symmetry and the Functional Architecture of Striate Cortex.” Philosophical Transactions of the Royal Society of London B: Biological Sciences 356 (1407): 299–330. https://doi.org/10.1098/rstb.2000.0769.
Carhart-Harris, R. L., and K. J. Friston. 2019. “REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.” Pharmacological Reviews 71 (3): 316–44. https://doi.org/10.1124/pr.118.017160.
Dregan, Alex, and Martin C. Gulliford. 2012. “Is Illicit Drug Use Harmful to Cognitive Functioning in the Midadult Years? A Cohort-Based Investigation.” American Journal of Epidemiology 175 (3): 218–27. https://doi.org/10.1093/aje/kwr315.
Lang, Misha Glenny and Callum. 2019. “How to Buy Drugs.” London Review of Books, November 7, 2019. https://www.lrb.co.uk/v41/n21/misha-glenny/how-to-buy-drugs.
McKenna, Dennis J. 2004. “Clinical Investigations of the Therapeutic Potential of Ayahuasca: Rationale and Regulatory Challenges.” Pharmacology & Therapeutics, Psychoactive Plants, 102 (2): 111–29. https://doi.org/10.1016/j.pharmthera.2004.03.002.
Nutt, D. J. 2009. “Equasy — an Overlooked Addiction with Implications for the Current Debate on Drug Harms.” Journal of Psychopharmacology 23 (1): 3–5. https://doi.org/10.1177/0269881108099672.
Olekalns, Nilss, and Peter Bardsley. 1996. “Rational Addiction to Caffeine: An Analysis of Coffee Consumption.” The Journal of Political Economy 104 (5): 1100–1104. https://doi.org/10.1086/262054.
Santos, R. G., J. Landeira-Fernandez, R. J. Strassman, V. Motta, and A. P. M. Cruz. 2007. “Effects of Ayahuasca on Psychometric Measures of Anxiety, Panic-Like and Hopelessness in Santo Daime Members.” Journal of Ethnopharmacology 112 (3): 507–13. https://doi.org/10.1016/j.jep.2007.04.012.
Schartner, Michael M., Robin L. Carhart-Harris, Adam B. Barrett, Anil K. Seth, and Suresh D. Muthukumaraswamy. 2017. “Increased Spontaneous MEG Signal Diversity for Psychoactive Doses of Ketamine, LSD and Psilocybin.” Scientific Reports 7 (April): 46421. https://doi.org/10.1038/srep46421.
Self, Will. n.d. “Pills, Powder and Smoke by Antony Loewenstein; Say Why to Drugs by Dr Suzi Gage – Review.” The Guardian: Books. Accessed January 25, 2020. https://www.theguardian.com/books/2020/jan/20/pills-powder-and-smoke-antony-loewenstein-say-why-to-drugs-suzi-gage-review-will-self.
Strassman, Rick J. 1995. “Human Psychopharmacology of N,N-Dimethyltryptamine.” Behavioural Brain Research, Serotonin, 73 (1–2): 121–24. https://doi.org/10.1016/0166-4328(96)00081-2.
White, James, and G. David Batty. 2011. “Intelligence Across Childhood in Relation to Illegal Drug Use in Adulthood: 1970 British Cohort Study.” Journal of Epidemiology and Community Health, November, jech–2011–200252. https://doi.org/10.1136/jech-2011-200252.
White, James W., Catharine R. Gale, and G. David Batty. 2012. “Intelligence Quotient in Childhood and the Risk of Illegal Drug Use in Middle-Age: The 1958 National Child Development Survey.” Annals of Epidemiology 22 (9): 654–57. https://doi.org/10.1016/j.annepidem.2012.06.001.